PeptidePicker
Home/Peptides/5-Amino-1MQ
MitochondrialResearch

5-Amino-1MQ

Also known as: 5-amino-1-methylquinolinium

A small-molecule NNMT inhibitor that disrupts fat storage at the cellular level, reversing diet-induced metabolic slowdown and shrinking fat cells.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~4–6 hours

Typical Dose

50–100 mg daily

Administration

Oral

Mechanism of Action

Inhibits Nicotinamide N-methyltransferase (NNMT), an enzyme overexpressed in obese tissue, to increase basal metabolic rate and force adipocyte shrinkage.

Key Research Areas

fat lossmetabolismNNMToralBMR

Frequently Asked Questions

What is 5-Amino-1MQ?
A small-molecule NNMT inhibitor that disrupts fat storage at the cellular level, reversing diet-induced metabolic slowdown and shrinking fat cells.
How does 5-Amino-1MQ work?
Inhibits Nicotinamide N-methyltransferase (NNMT), an enzyme overexpressed in obese tissue, to increase basal metabolic rate and force adipocyte shrinkage.
What is the recommended dosage for 5-Amino-1MQ?
The typical research dosage is 50–100 mg daily, administered via Oral. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of 5-Amino-1MQ?
The half-life of 5-Amino-1MQ is approximately ~4–6 hours. This affects dosing frequency and timing in research protocols.
Is 5-Amino-1MQ FDA approved?
5-Amino-1MQ is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Research Disclaimer

The information provided about 5-Amino-1MQ is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Mitochondrial